Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Explore effective wise investment strategies that can help you achieve long-term gains. Learn how to grow your wealth sustainably.
27,808 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
The Pentagon’s fight with Anthropic has become a landmark test of how the U.S. will regulate powerful AI. Markets and...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
Bitcoin holds near a critical level as CME's volatility futures near launch, stoking bets on a push toward the mid-80...
Signals of value used to prove skill and effort. Today, AI and automation blur those lines. This guide shows how to a...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
NVIDIA reports a surge in networking revenue and a strategic pivot toward AI infrastructure, signaling a shift from c...
Retirees face a surprising two-year lag between last-year earnings and Medicare premium changes, even when Social Sec...
Market pullbacks happen. Some assets recover faster than others. This article explains why a Vanguard ETF with a shor...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
Strategy stock has fallen 46% in a single month as Bitcoin declines, prompting a split in investor views: is this dea...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...